Erypro Safe 40,000 IU Injection (Recombinant Human Erythropoietin Alfa) – 1 ml Prefilled Syringe
Premium Quality

Erypro Safe 40,000 IU Injection (Recombinant Human Erythropoietin Alfa) – 1 ml Prefilled Syringe

$172.50

$215.63Save 20%
📦 Unit: pre filled pen💰 Price Per pre filled pen

Product Overview

Treat anemia from CKD & cancer with Erypro Safe 40,000 IU (Epoetin Alfa) prefilled syringe. Stimulates red blood cell production. Consult doctor.

100% Authentic
Secure Checkout
Overview

About this Medicine

Erypro Safe 40,000 IU Injection, featuring Recombinant Human Erythropoietin Alfa, is a vital pharmaceutical solution meticulously designed to address specific types of anemia. This advanced medicine falls under the category of erythropoiesis-stimulating agents (ESAs), which work by mimicking the natural hormone erythropoietin produced by the kidneys. Its primary function is to stimulate the bone marrow to produce more red blood cells, effectively raising hemoglobin levels and improving oxygen transport throughout the body. Patients undergoing certain cancer treatments, particularly chemotherapy, often experience a significant drop in red blood cell counts, leading to profound fatigue, weakness, and a diminished quality of life. Erypro Safe 40,000 IU offers a targeted approach to manage this chemotherapy-induced anemia, potentially reducing the need for uncomfortable and inconvenient red blood cell transfusions. Similarly, individuals living with chronic kidney disease frequently develop anemia due to impaired erythropoietin production. For these patients, Erypro Safe provides a crucial therapeutic option to correct their anemia, helping them regain energy and maintain daily functions. Administered via a convenient 1 ml prefilled syringe, Erypro Safe 40,000 IU ensures precise dosing and ease of use, whether in a clinical setting or for self-administration under medical guidance. Before starting treatment, it is essential for patients to undergo a thorough medical evaluation, including assessment of iron stores, as adequate iron levels are necessary for Erypro Safe to be effective. Throughout the course of therapy, regular monitoring of hemoglobin levels and blood pressure is critical to ensure both efficacy and patient safety. It is also important to note that while Erypro Safe effectively manages anemia, it does not treat the underlying cause of chronic kidney disease or cancer itself. Its role is supportive, aimed at improving patient well-being and mitigating anemia-related complications. Always consult your healthcare professional to determine if Erypro Safe 40,000 IU Injection is the right treatment for your condition and to understand its complete risk-benefit profile, including potential side effects and interactions with other medications.